Clinical Trial Update: Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated how meropenem penetrates the blood-brain barrier in patients with central nervous system infections and explored dosing optim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Infections

Drugs mentioned

• Meropenem (Meropenem)

Snippet

Sponsor: Huashan Hospital | Conditions: Central Nervous System Infections | Phase 4 | Status: COMPLETED